Literature DB >> 8536781

Expression of a cell surface antigen recognized by the monoclonal antibody AUA1 in bladder carcinoma: an immunohistochemical study.

J Zorzos1, A Zizi, A Bakiras, D Pectasidis, D V Skarlos, H Zorzos, J Elemenoglou, M Likourinas.   

Abstract

The expression of a cell surface antigen recognized by the epithelium-specific, tumor-associated monoclonal antibody (Moab) AUA1 has been studied in 22 cases of normal urothelium, 7 cases of dysplastic urothelium and 86 cases of transitional cell carcinoma. Tissue specimens were stained with the conventional hematoxylin-eosin technique as well as with the indirect immunoperoxidase technique using Moab AUA1. Results showed that: (a) Moab AUA1 reacts mainly with cells of high or intermediate grade transitional cell carcinoma and with a restricted number of normal urothelial cells, and (b) antigenic heterogeneity exists between tumors of the same grade and within the same tumor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8536781     DOI: 10.1159/000475060

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

1.  Cytoplasmic tail regulates the intercellular adhesion function of the epithelial cell adhesion molecule.

Authors:  M Balzar; H A Bakker; I H Briaire-de-Bruijn; G J Fleuren; S O Warnaar; S V Litvinov
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

Review 2.  The current status of tailor-made medicine with molecular biomarkers for patients with clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toshiro Terachi; Toyoaki Uchida; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2014-01       Impact factor: 5.150

3.  Expression pattern of epithelial cell adhesion molecule on normal and malignant colon tissues.

Authors:  Xin Xie; Chun-Yan Wang; Yun-Xin Cao; Wei Wang; Ran Zhuang; Li-Hua Chen; Na-Na Dang; Liang Fang; Bo-Quan Jin
Journal:  World J Gastroenterol       Date:  2005-01-21       Impact factor: 5.742

4.  Genome-wide changes accompanying the knockdown of Ep-CAM in retinoblastoma.

Authors:  Moutushy Mitra; Mallikarjuna Kandalam; Rama Shanker Verma; Krishnan UmaMaheswari; Subramanian Krishnakumar
Journal:  Mol Vis       Date:  2010-05-11       Impact factor: 2.367

5.  A Phase I study of an intravesically administered immunotoxin targeting EpCAM for the treatment of nonmuscle-invasive bladder cancer in BCGrefractory and BCG-intolerant patients.

Authors:  Mark Kowalski; Joycelyn Entwistle; Jeannick Cizeau; Demi Niforos; Shauna Loewen; Wendy Chapman; Glen C MacDonald
Journal:  Drug Des Devel Ther       Date:  2010-11-15       Impact factor: 4.162

Review 6.  The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology.

Authors:  Manon J Winter; Iris D Nagtegaal; J Han J M van Krieken; Sergey V Litvinov
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

7.  Epithelial cell adhesion molecule (Ep-CAM) modulates cell-cell interactions mediated by classic cadherins.

Authors:  S V Litvinov; M Balzar; M J Winter; H A Bakker; I H Briaire-de Bruijn; F Prins; G J Fleuren; S O Warnaar
Journal:  J Cell Biol       Date:  1997-12-01       Impact factor: 10.539

Review 8.  Clinical targeting recombinant immunotoxins for cancer therapy.

Authors:  Meng Li; Zeng-Shan Liu; Xi-Lin Liu; Qi Hui; Shi-Ying Lu; Lin-Lin Qu; Yan-Song Li; Yu Zhou; Hong-Lin Ren; Pan Hu
Journal:  Onco Targets Ther       Date:  2017-07-20       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.